• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct15
Jiuzhou Pharma released FY2025 9 Months Earnings on October 15 After-Market (BJT), with actual revenue of CNY 4.16 B and EPS of CNY 0.8399
01:00
Jiuzhou Pharma released FY2025 Q3 earnings on October 15 After-Market (BJT), actual revenue CNY 1.29 B, actual EPS CNY 0.2498 (forecast EPS CNY 0.28)
01:00
Oct8
Jiuzhou Pharma to Release FY2025 Q3 Earnings on October 16 After-Market (BJT), Forecast EPS CNY 0.28
00:08
Aug12
Ruibo Suzhou Passes US FDA cGMP Inspection
07:41
Jiuzhou Pharmaceutical Reports Revenue and Profit Growth in 2025 H1
00:46
Aug5
Jiuzhou Pharmaceutical Reports Revenue and Net Profit Growth in H1 2025
08:13

Schedules & Filings

Schedules
Filings
Oct15
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 1.29 B, Net Income 221.82 M, EPS 0.2498

Sep8
Distribution Plan(CST)

Cash dividend 0.2 CNY

Distribution Plan(CST)

Cash dividend 0.2 CNY

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More